تجاوز إلى المحتوى الرئيسي
# العنوان نوع الخبر التاريخ رابط الخبر
70 SFDA’s Advice on the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19 Precautions
69 Risk of potentially fatal respiratory depression with benzodiazepines and opioids Warning
68 Concern on Potential Risk of Respiratory Depression Associated with Gabapentinoids (pregabalin and gabapentin) medications Warning
67 Ceftriaxone: a reminder for the risk of hypersensitivity Warning
66 Concerns on paracetamol overdose in children Warning
65 Risk of neuropsychiatric reactions with the use of Montelukast Warning
64 Risk of Myocarditis Associated With the Use of Atezolizumab Warning and Precaution
63 Nivolumab Precautions
62 The Risk of Rare but Serious Infection in the Genital Area with Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Warning
61 Ambrisentan Precautions
Displaying 101 - 110 of 170